Development of Mcl-1 inhibitors for cancer therapy
2020 · European Journal of Medicinal Chemistry · 87 citations
https://doi.org/10.1016/j.ejmech.2020.113038
A
Arvind Negi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
2.1K
Citations
24
h-index
47
i10-index
Arvind Negi is an academic researcher from University of Helsinki. The author has contributed to research in topics: Computational Drug Discovery Methods & Synthesis and biological activity & Chemical Synthesis and Analysis. The author has an h-index of 24, co-authored 95 publications.
ORCID: 0000-0002-0341-9291Papers by this author
worksNanotheranostics to target antibiotic-resistant bacteria: Strategies and applications
2023 · OpenNano · 74 citations
https://doi.org/10.1016/j.onano.2023.100138
Surface modifications of nanocellulose for drug delivery applications; a critical review
2023 · Current Opinion in Biomedical Engineering · 57 citations
https://doi.org/10.1016/j.cobme.2023.100475
Inverse docking based screening and identification of protein targets for Cassiarin alkaloids against Plasmodium falciparum
2018 · Saudi Pharmaceutical Journal · 24 citations
https://doi.org/10.1016/j.jsps.2018.01.017
Alkoxide-based solvent dyeing: a feasible strategy for pollution minimization and sustainable approach for the reactive dyeing of cellulosic materials
2024 · Cellulose · 13 citations
https://doi.org/10.1007/s10570-024-06059-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat